Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coldamaris oral spray for chemotherapy-induced oral mucositis in children with acute lymphoblastic leukemia
IRCT20260815070650N1Phase 3Recruiting
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2026
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, single-blind trial of Iota-carrageenan in stomatitis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Incidence of severe grade 3 or 4 oral mucositis and Maximum mucositis severity during induction chemotherapy. Started Sep 2026; status: recruiting.
02
Drugs
Iota-carrageenan
03
Conditions
stomatitis
Beyond the preview
Go deeper on IRCT20260815070650N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260815070650N1.